FDA Alerts

Psoriasis
Psoriasis
FDA Approves Updated Label for Psoriasis Drug
05/22/2018
The FDA has approved a label update for a biologic used for the treatment of adult patients with moderate-to-severe plaque psoriasis
05/22/2018
Osteoporosis
Osteoporosis
FDA Expands Indication of Osteoporosis Drug
05/22/2018
The US Food and Drug Administration has approved a fifth indication for a human monoclonal antibody commonly used for the treatment of osteoporosis.
05/22/2018
Thrombocytopenia
Thrombocytopenia
FDA Approves New Option for Thrombocytopenia
05/21/2018
The US Food and Drug Administration has approved a new drug for the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure.
05/21/2018
prevention
prevention
FDA Approves Preventive Migraine Treatment
05/18/2018
Following the success of 3 clinical trials, the US Food and Drug Administration granted approval to a once-monthly, self-injectable preventive treatment for adults with migraine.
05/18/2018
FDA
FDA
FDA Approves First Non-Opioid Drug for Opioid Withdrawal
05/17/2018
The US Food and Drug Administration has granted approval to the first non-opioid treatment option for the management of withdrawal symptoms in adults who abruptly discontinue opioids.
05/17/2018
FDA
FDA
FDA Approves New Biosimilar for Anemia
05/15/2018
The US Food and Drug Administration has approved the first biosimilar to epoetin alfa for the treatment of anemia due to various causes.
05/15/2018
FDA
FDA
FDA Expands MS Drug Indication
05/14/2018
The US Food and Drug Administration has expanded the indication of an approved MS drug, making it the first drug approved for use in some pediatric patients with relapsing multiple sclerosis.
05/14/2018
FDA
FDA
FDA Increases Dosing Flexibility of Hyperkalemia Drug
05/09/2018
The US Food and Drug Administration has approved a supplemental new drug application for the use of a previously approved drug for the treatment of hyperkalemia which may allow for more flexibility and ease...
05/09/2018
FDA
FDA
FDA Approves Drug Combo for Overactive Bladder
05/09/2018
The US Food and Drug Administration has approved a supplemental new drug application for the use of a combination therapy to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and...
05/09/2018
FDA
FDA
FDA Approves New ADPKD Drug
04/25/2018
The US Food and Drug Administration has approved the first drug to slow the decline of kidney function in adults with a high risk of rapidly progressing autosomal dominant polycystic kidney disease.
04/25/2018